US7820422B2
(en)
*
|
2005-06-16 |
2010-10-26 |
Centre National De La Recherche Scientifique (Cnrs) |
Efficient production of oligosaccharides using metabolically engineered microorganisms
|
US20070202578A1
(en)
*
|
2005-08-26 |
2007-08-30 |
Centre National De La Recherche Scientifique (Cnrs) |
Production of globosides oligosaccharides using metabolically engineered microorganisms
|
CN102257128A
(zh)
|
2008-12-19 |
2011-11-23 |
詹内怀恩生物技术股份有限公司 |
岩藻糖化化合物的合成
|
NZ605093A
(en)
*
|
2010-07-12 |
2014-05-30 |
Univ Gent |
Metabolically engineered organisms for the production of added value bio-products
|
MX354145B
(es)
*
|
2010-11-03 |
2018-02-14 |
Terravia Holdings Inc |
Aceites microbianos con puntos de fluidez reducidos, fluidos dielectricos producidos a partir de estos y metodos relacionados.
|
US9816107B2
(en)
|
2011-07-29 |
2017-11-14 |
The University Of Wyoming |
Transgenic insect cells comprising a bacterial GlcNAc-6-P 2′-epimerase
|
WO2013019625A2
(en)
|
2011-07-29 |
2013-02-07 |
The University Of Wyoming |
Methods of using a bacterial glcnac-6-p 2'-epimerase to promote sialylation of glycoconjugates
|
EP2900829B1
(en)
*
|
2012-09-25 |
2019-06-26 |
Glycom A/S |
Glycoconjugate synthesis
|
WO2014135167A1
(en)
*
|
2013-03-08 |
2014-09-12 |
Glycom A/S |
Purification of oligosaccaharides by reversible derivatization
|
DK2970872T3
(da)
*
|
2013-03-14 |
2019-01-02 |
Glycosyn LLC |
Mikroorganismer og fremgangsmåder til fremstilling af sialylerede og N-acetylglucosamin-holdige oligosaccharider
|
PL2999358T3
(pl)
|
2013-05-22 |
2021-12-20 |
Glycom A/S |
Syntetyczna mieszanina oligosacharydów do leczenia mikrobioty ssaka
|
CN104342469B
(zh)
*
|
2013-08-01 |
2017-06-30 |
东北师范大学 |
一种生物转化制备单唾液酸四己糖神经节苷脂的方法
|
WO2015032413A1
(en)
|
2013-09-06 |
2015-03-12 |
Glycom A/S |
Fermentative production of oligosaccharides
|
CN103602627B
(zh)
*
|
2013-11-25 |
2015-03-18 |
武汉中科光谷绿色生物技术有限公司 |
一种产n-乙酰神经氨酸大肠杆菌工程菌及其构建方法和应用
|
US11926858B2
(en)
|
2014-06-27 |
2024-03-12 |
Glycom A/S |
Oligosaccharide production
|
US10731193B2
(en)
|
2014-06-27 |
2020-08-04 |
Glycom A/S |
Oligosaccharide production
|
US9616114B1
(en)
|
2014-09-18 |
2017-04-11 |
David Gordon Bermudes |
Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
|
CN107108677B
(zh)
|
2014-10-24 |
2020-08-07 |
格礼卡姆股份公司 |
Hmo的混合物
|
JP7182872B2
(ja)
|
2014-10-29 |
2022-12-05 |
グリコム・アクティーゼルスカブ |
過敏性腸症候群の治療のための合成組成物および方法
|
US11040050B2
(en)
|
2014-10-29 |
2021-06-22 |
Glycom A/S |
Composition comprising HMSs/HMOs and use thereof
|
DK3212198T3
(en)
|
2014-10-29 |
2021-03-29 |
Glycom As |
Synthetic composition and method for promoting mucosal healing
|
US11040049B2
(en)
|
2014-10-29 |
2021-06-22 |
Glycom A/S |
Composition comprising HMSs/HMOs and use thereof
|
JP6765372B2
(ja)
*
|
2014-11-14 |
2020-10-07 |
インビオース エヌ.ヴェ.Inbiose N.V. |
ラクトース死滅に耐性である変異体微生物
|
CN107106584A
(zh)
|
2014-12-08 |
2017-08-29 |
格礼卡姆股份公司 |
用于治疗代谢障碍的合成组合物
|
US10987368B2
(en)
|
2014-12-08 |
2021-04-27 |
Glycom A/S |
Synthetic composition for preventing or treating CVD
|
US10835544B2
(en)
|
2014-12-08 |
2020-11-17 |
Glycom A/S |
Synthetic composition for regulating satiety
|
US10881674B2
(en)
|
2014-12-08 |
2021-01-05 |
Glycom A/S |
Synthetic composition for treating metabolic disorders
|
DK3277287T3
(da)
|
2015-03-31 |
2024-01-08 |
Glycom As |
Blandinger af humane mælke-oligosaccharider, der omfatter 3 '-o-sialyllactose
|
ES2870973T3
(es)
|
2015-06-09 |
2021-10-28 |
Glycom As |
Mezclas ternarias de 6'-SL, LNnT y LST c
|
EP3141610A1
(en)
*
|
2015-09-12 |
2017-03-15 |
Jennewein Biotechnologie GmbH |
Production of human milk oligosaccharides in microbial hosts with engineered import / export
|
DK3349763T3
(en)
|
2015-09-14 |
2021-11-15 |
Glycom As |
Composition for use in microbiota modulation
|
PL3368046T3
(pl)
|
2015-10-28 |
2022-11-28 |
Glycom A/S |
Syntetyczna kompozycja i sposób modulowania funkcji mózgu i zachowania
|
US10780103B2
(en)
|
2015-10-28 |
2020-09-22 |
Glycom A/S |
Synthetic composition and method for modulating emotion and mood disorders
|
CN108348536B
(zh)
|
2015-11-17 |
2021-09-24 |
格礼卡姆股份公司 |
治疗抗生素相关性并发症的合成组合物
|
CA3006400A1
(en)
|
2015-11-30 |
2017-06-08 |
Limmatech Biologics Ag |
Methods of producing glycosylated proteins
|
MY186217A
(en)
|
2015-12-15 |
2021-06-30 |
Nestle Sa |
Mixture of hmos
|
WO2017101958A1
(en)
|
2015-12-18 |
2017-06-22 |
Glycom A/S |
Fermentative production of oligosaccharides
|
EP3419630A4
(en)
|
2016-02-24 |
2019-11-06 |
Glycom A/S |
SYNTHETIC COMPOSITION OF MICROBIOTIC MODULATION
|
EP3426670A4
(en)
|
2016-03-07 |
2019-11-13 |
Glycom A/S |
SEPARATION OF OLIGOSACCHARIDES FROM A FERMENTATION BROTH
|
WO2017190755A1
(en)
|
2016-05-05 |
2017-11-09 |
Glycom A/S |
Composition comprising hmos for use in the treatment of mast cell mediated visceral hypersensitivity and/or pain
|
PL3452050T3
(pl)
|
2016-05-05 |
2023-06-12 |
Glycom A/S |
Kompozycja zawierająca hmo do leczenia biegunki niezakaźnej
|
WO2017198276A1
(en)
|
2016-05-19 |
2017-11-23 |
Glycom A/S |
Synthetic composition
|
US11419884B2
(en)
|
2016-06-24 |
2022-08-23 |
Glycom A/S |
Compositions comprising HMOS, their production and use for the prevention and/or treatment of viral and/or bacterial infections
|
US11129906B1
(en)
|
2016-12-07 |
2021-09-28 |
David Gordon Bermudes |
Chimeric protein toxins for expression by therapeutic bacteria
|
US11180535B1
(en)
|
2016-12-07 |
2021-11-23 |
David Gordon Bermudes |
Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
|
EP3562951A1
(en)
|
2016-12-27 |
2019-11-06 |
Inbiose N.V. |
In vivo synthesis of sialylated compounds
|
WO2018157900A1
(en)
|
2017-03-01 |
2018-09-07 |
Glycom A/S |
Synthetic composition for microbiota modulation
|
EP3634429A4
(en)
|
2017-05-09 |
2020-11-04 |
Glycom A/S |
SYNTHETIC COMPOSITION FOR MICROBIOTE MODULATION
|
US11541068B2
(en)
|
2017-05-24 |
2023-01-03 |
Glycom A/S |
HMO compositions and methods for reducing autism spectrum disorder symptoms
|
EP3630123A4
(en)
|
2017-05-24 |
2020-10-28 |
Glycom A/S |
SYNTHETIC COMPOSITION WITH ONE OR MORE HUMAN MILK OLIGOSACCHARIDES (HMOS)
|
US20200123184A1
(en)
|
2017-06-30 |
2020-04-23 |
Glycom A/S |
Purification of oligosaccharides
|
US11505567B2
(en)
|
2017-07-12 |
2022-11-22 |
Glycom A/S |
Amorphous mixture comprising a neutral mono- or oligosaccharide and an acidic non-carbohydrate component
|
EP3658678A1
(en)
|
2017-07-26 |
2020-06-03 |
Jennewein Biotechnologie GmbH |
Sialyltransferases and their use in producing sialylated oligosaccharides
|
US11524019B2
(en)
|
2017-08-21 |
2022-12-13 |
Glycom A/S |
Synthetic composition for reducing allergy symptoms
|
EP3456836A1
(en)
|
2017-09-13 |
2019-03-20 |
Glycom A/S |
Separation of sialylated oligosaccharides from fermentation broth
|
EP3703698A4
(en)
|
2017-11-02 |
2021-08-18 |
Glycom A/S |
ONE OR MORE HMOS TO REDUCE OR PREVENT FATIGUE AND / OR IMPROVE CONCENTRATION
|
KR20200096263A
(ko)
|
2017-11-30 |
2020-08-11 |
글리콤 에이/에스 |
밀 민감증을 치료하기 위한 hmo 혼합물
|
US11602545B2
(en)
|
2017-12-05 |
2023-03-14 |
Glycom A/S |
Human milk oligosaccharides for treating migraine
|
CA3085931A1
(en)
*
|
2017-12-15 |
2019-06-20 |
Glycosyn LLC |
Sialyltransferases and uses thereof
|
US11304966B2
(en)
|
2017-12-22 |
2022-04-19 |
Glycom A/S |
Composition comprising HMOs for preventing or reducing nociception
|
GB2573539A
(en)
|
2018-05-09 |
2019-11-13 |
Mjn Us Holdings Llc |
Wellbeing supplement for postpartum maternal nutrition
|
PL3575404T3
(pl)
|
2018-05-28 |
2023-02-06 |
Chr. Hansen HMO GmbH |
Fermentacyjna produkcja sacharydów sialilowanych
|
KR20210016557A
(ko)
|
2018-05-31 |
2021-02-16 |
글리콤 에이/에스 |
자가면역 질환 치료를 위한 hmo 혼합물
|
PL3801037T3
(pl)
*
|
2018-06-01 |
2023-01-23 |
Chr. Hansen HMO GmbH |
Prosty sposób oczyszczania sialilolaktozy
|
JP2022513524A
(ja)
|
2018-12-19 |
2022-02-08 |
グリコム・アクティーゼルスカブ |
低fodmap食を使用してヒトを治療するための組成物および方法
|
CN109852651B
(zh)
*
|
2018-12-27 |
2022-03-15 |
大连大学 |
一种重组大肠杆菌质周腔内生产唾液酸修饰n-糖基化重组蛋白方法
|
CN110195043A
(zh)
*
|
2019-05-15 |
2019-09-03 |
武汉格莱利生物科技有限公司 |
一种高水溶性的cgta酶及其制备方法和应用
|
EP3789495A1
(en)
*
|
2019-09-03 |
2021-03-10 |
Jennewein Biotechnologie GmbH |
Production of sialylated oligosaccharides in bacillus cells
|
US20220380785A1
(en)
*
|
2019-11-01 |
2022-12-01 |
The University Of British Columbia |
Compositions and methods for sialylated mucin-type o-glycosylation of therapeutic proteins
|
WO2021094133A2
(en)
|
2019-11-13 |
2021-05-20 |
Basf Se |
Enzymatic hydrolysis of 2',3-difucosyllactose
|
CN114901825A
(zh)
|
2019-12-18 |
2022-08-12 |
因比奥斯公司 |
在宿主细胞中产生唾液酸化寡糖
|
KR20220116001A
(ko)
*
|
2019-12-19 |
2022-08-19 |
글리콤 에이/에스 |
발효액으로부터 시알릴화된 올리고사카라이드의 분리
|
EP3848471A1
(en)
*
|
2020-01-10 |
2021-07-14 |
Chr. Hansen HMO GmbH |
Sequential fermentative production of oligosaccharides
|
WO2021170620A1
(en)
|
2020-02-24 |
2021-09-02 |
Carbocode S.A. |
Synthesis of glycosyl fluorides
|
EP4110934A1
(en)
|
2020-02-24 |
2023-01-04 |
Carbocode S.A. |
Synthesis of c-glycosides of interest
|
EP4110935A2
(en)
|
2020-02-24 |
2023-01-04 |
Carbocode S.A. |
Synthesis of glycosylated sphingoid bases of interest or analogues thereof
|
CN111500660A
(zh)
*
|
2020-04-23 |
2020-08-07 |
武汉糖智药业有限公司 |
一种单唾液酸四己糖神经节苷脂的合成方法
|
EP3954769A1
(en)
*
|
2020-08-10 |
2022-02-16 |
Inbiose N.V. |
Production of oligosaccharide mixtures by a cell
|
FR3110176B1
(fr)
|
2020-05-12 |
2022-05-13 |
Institut Nat Des Sciences Appliquees De Toulouse |
Souche et procédé de production d’oligosaccharides
|
WO2022034067A1
(en)
|
2020-08-10 |
2022-02-17 |
Inbiose N.V. |
Production of an oligosaccharide mixture by a cell
|
EP4281564A1
(en)
|
2021-01-22 |
2023-11-29 |
Glycom A/S |
New major facilitator superfamily (mfs) protein (fred) in production of sialylated hmos
|
CA3209837A1
(en)
|
2021-01-29 |
2022-08-04 |
Centre National De La Recherche Scientifique (Cnrs) |
Novel sialosides and their use in therapy
|
CN117157394A
(zh)
|
2021-04-16 |
2023-12-01 |
因比奥斯公司 |
发酵生产
|
KR20230170961A
(ko)
*
|
2021-04-16 |
2023-12-19 |
인바이오스 엔.브이. |
시알릴화 이당 및/또는 올리고당의 세포 생산
|
WO2022223430A1
(en)
|
2021-04-19 |
2022-10-27 |
Dsm Ip Assets B.V. |
A composition of enzymes and human milk oligosaccharides
|
WO2022242860A1
(en)
|
2021-05-20 |
2022-11-24 |
Chr. Hansen A/S |
Sequential fermentative production of oligosaccharides
|
WO2022263425A1
(en)
|
2021-06-15 |
2022-12-22 |
Dsm Ip Assets B.V. |
Separation of human milk oligosaccharides from a fermentation broth
|
EP4355464A1
(en)
|
2021-06-15 |
2024-04-24 |
DSM IP Assets B.V. |
Separation of human milk oligosaccharides from a fermentation broth
|
WO2022263424A1
(en)
|
2021-06-15 |
2022-12-22 |
Dsm Ip Assets B.V. |
Separation of human milk oligosaccharides from a fermentation broth
|
WO2022263426A1
(en)
|
2021-06-15 |
2022-12-22 |
Dsm Ip Assets B.V. |
Separation of human milk oligosaccharides from a fermentation broth
|
WO2023097604A1
(zh)
*
|
2021-12-02 |
2023-06-08 |
岩唐生物科技(杭州)有限责任公司 |
分离的多肽及其应用
|
DK181319B1
(en)
|
2022-03-02 |
2023-08-10 |
Dsm Ip Assets Bv |
Genetically engineered cells and methods comprising use of a sialyltransferase for in vivo synthesis of 3’sl
|
WO2023166035A2
(en)
|
2022-03-02 |
2023-09-07 |
Dsm Ip Assets B.V. |
New sialyltransferases for in vivo synthesis of 3'sl and 6'sl
|
DK202270078A1
(en)
|
2022-03-02 |
2023-12-04 |
Dsm Ip Assets Bv |
New sialyltransferases for in vivo synthesis of lst-a
|
CN114965543B
(zh)
*
|
2022-06-13 |
2023-10-20 |
青岛科技大学 |
壳寡糖nmr波谱的归属及脱乙酰度相关指标的测定方法
|
DK202200588A1
(en)
|
2022-06-20 |
2024-02-23 |
Dsm Ip Assets Bv |
Mixture of fucosylated HMOs
|
DK202200591A1
(en)
|
2022-06-20 |
2024-02-15 |
Dsm Ip Assets Bv |
New sialyltransferases for in vivo synthesis of lst-c
|